Novocure Ltd
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | 0.0% | -2.2% | +8.1% | +0.8% | +1.5% | +0.6% | -0.2% | +9.3% | -40.9% | -2.0% | +0.9% | |
| – | -1.3% | -3.1% | +9.0% | +0.2% | +1.0% | -1.6% | -0.6% | +10.8% | -46.1% | -2.3% | +1.1% | |
| – | +55.5% | +88.4% | -62.9% | +10.1% | -11.7% | -22.3% | +17.6% | +130.3% | -70.0% | -5.9% | -3.7% | |
| – | -1.2% | -4.4% | +9.7% | +0.9% | -0.4% | -3.0% | -2.1% | +13.7% | -55.8% | -3.4% | -0.3% | |
| – | -12.7% | +12.3% | -25.3% | +3.6% | +52.2% | +16.1% | +8.9% | -34.0% | +35.3% | -19.1% | +56.3% | |
| – | +3.7% | +11.1% | -4.6% | -3.3% | -10.3% | +12.5% | +1.9% | -2.8% | +5.1% | +5.7% | -2.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +4.1% | -2.8% | +11.6% | +1.3% | +2.3% | +0.7% | +1.1% | +13.8% | -54.5% | -1.4% | 0.0% | |
| – | +14.0% | -10.5% | +5.6% | +334.5% | +2.9% | -1.7% | +0.9% | +3.5% | -71.2% | -2.5% | +1.4% | |
| – | -89.4% | +823.1% | +4.1% | +605.4% | +1.6% | -1.3% | +0.1% | +0.1% | -97.9% | – | – | |
| – | +18.5% | -10.7% | +6.9% | +1.3% | +15.1% | -9.5% | +9.0% | +14.7% | +2.8% | +4.1% | +2.7% | |
| – | +0.1% | +0.1% | +14.7% | -85.1% | +0.2% | +0.2% | +0.2% | +99.4% | +0.2% | +0.2% | +0.2% | |
| – | -7.9% | -0.9% | +0.7% | -0.3% | -0.2% | +0.5% | -3.5% | -2.3% | -0.3% | -2.9% | +2.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.2% | +0.3% | +0.4% | +0.5% | -0.4% | +2.3% | +1.2% | +0.3% | -0.4% | +2.4% | +1.6% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.